Browse Category

Investment Updates News 22 December 2025 - 10 January 2026

AST SpaceMobile (ASTS) Stock News: BlueBird 6 Commissioning Timeline, Insider Trades, and Analyst Targets Ahead of Monday’s Open

AST SpaceMobile (ASTS) Stock News: BlueBird 6 Commissioning Timeline, Insider Trades, and Analyst Targets Ahead of Monday’s Open

NEW YORK, Dec. 28, 2025, 10:06 a.m. ET — Market closed (weekend). AST SpaceMobile, Inc. (NASDAQ: ASTS) heads into the final trading week of 2025 with investors balancing a major technical milestone—its record-size BlueBird 6 satellite now in orbit—against a
Gilead Sciences (GILD) Stock News Today: New Herpes Deal, TrumpRx Pricing Pact, and Fresh Wall Street Forecasts (Dec. 22, 2025)

Gilead Sciences (GILD) Stock News Today: New Herpes Deal, TrumpRx Pricing Pact, and Fresh Wall Street Forecasts (Dec. 22, 2025)

Gilead Sciences, Inc. (NASDAQ: GILD) opened the holiday-shortened week with a mix of pipeline expansion and policy-driven uncertainty—two themes that can quickly move large-cap biopharma stocks even when overall market volume is lighter than usual. On Monday, December 22, 2025,
Amicus Therapeutics (FOLD) Stock News Today: BioMarin’s $14.50 Buyout, Fresh Analyst Forecasts, and Key Dates to Watch (Dec. 22, 2025)

Amicus Therapeutics (FOLD) Stock News Today: BioMarin’s $14.50 Buyout, Fresh Analyst Forecasts, and Key Dates to Watch (Dec. 22, 2025)

Amicus Therapeutics, Inc. (NASDAQ: FOLD) stock is no longer trading like a typical biotech momentum name—at least not this week. As of December 22, 2025, the stock is hovering around $14.18, tightly anchored to the $14.50 per-share all-cash buyout BioMarin
1 2 3
Go toTop